tirzepatide surmount 3 for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial ESC 2025: post-hoc SURMOUNT-5 data

Rx weight loss with Ro Get access to prescription weight loss medication online Bottom line Tirzepatide (the active ingredient in Mounjaro and Zepbound) is a dual GLP-1 and GIP receptor agonist

Other combination options include metformin for insulin resistance, topiramate for appetite and food cravings, and naltrexone/bupropion for reward-driven eating patterns

By building a "web" of support rather than just taking a single isolated nutrient, you mimic the way these compounds are found in natureworking together to maintain balance

We received comments concerning participant burden that may be introduced by ASM

The most effective treatments focus on finding and resolving medical conditions at the root of the problem

Figure 1 Characteristics of included studies To ensure methodological clarity and appropriately weight the evidence, the included literature is organized into four distinct categories: completed head-to-head trials, contextual cardiovascular outcome trials, real-world observational studies, and ongoing (non-analytical) studies